v3.26.1
Condensed Statements of Changes in Stockholders’ Equity (Unaudited) - USD ($)
Preferred Stock
Common Stock
Treasury Stock
Additionalb Paid-In Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2024   $ 4 $ (172) $ 75,173,793 $ (71,862,617) $ 3,311,008
Balance (in Shares) at Dec. 31, 2024   42,423        
Balance (in Shares) at Dec. 31, 2024     1,550      
Stock-based compensation expense   1,158 1,158
Vesting of restricted stock   14,743 14,743
Vesting of restricted stock (in Shares)   4        
Issuance of common stock through exercise of prefunded warrants   $ 2 (2)
Issuance of common stock through exercise of prefunded warrants (in Shares)   19,992        
Net loss   (1,658,396) (1,658,396)
Balance at Mar. 31, 2025   $ 6 $ (172) 75,189,692 (73,521,013) 1,668,513
Balance (in Shares) at Mar. 31, 2025   62,419        
Balance (in Shares) at Mar. 31, 2025     1,550      
Balance at Dec. 31, 2024   $ 4 $ (172) 75,173,793 (71,862,617) 3,311,008
Balance (in Shares) at Dec. 31, 2024   42,423        
Balance (in Shares) at Dec. 31, 2024     1,550      
Net loss           (2,705,639)
Balance at Jun. 30, 2025   $ 6 $ (172) 75,190,395 (74,568,256) 621,973
Balance (in Shares) at Jun. 30, 2025   62,425        
Balance (in Shares) at Jun. 30, 2025     1,550      
Balance at Mar. 31, 2025   $ 6 $ (172) 75,189,692 (73,521,013) 1,668,513
Balance (in Shares) at Mar. 31, 2025   62,419        
Balance (in Shares) at Mar. 31, 2025     1,550      
Stock-based compensation expense recovery   (66) (66)
Offering costs in connection with the on-going Public Offering   (1,100) (1,100)
Vesting of restricted stock   1,869 1,869
Vesting of restricted stock (in Shares)   6        
Net loss   (1,047,243) (1,047,243)
Balance at Jun. 30, 2025   $ 6 $ (172) 75,190,395 (74,568,256) 621,973
Balance (in Shares) at Jun. 30, 2025   62,425        
Balance (in Shares) at Jun. 30, 2025     1,550      
Balance at Dec. 31, 2025 $ 1 $ 21 $ (172) 85,438,530 (82,350,149) $ 3,088,231
Balance (in Shares) at Dec. 31, 2025 6,875 211,976       211,976
Balance (in Shares) at Dec. 31, 2025     39     39
Stock-based compensation expense 153 $ 153
Vesting of restricted stock 875 875
Vesting of restricted stock (in Shares)   3        
Issuance of common stock through exercise of prefunded warrants $ 3 (3)
Issuance of common stock through exercise of prefunded warrants (in Shares)   32,312        
Issuance of common stock through conversion of Series C convertible preferred stock $ (1) $ 50 (49)  
Issuance of common stock through conversion of Series C convertible preferred stock (in Shares) (3,830) 497,287        
Net loss (2,275,221) (2,275,221)
Balance at Mar. 31, 2026 $ 74 $ (172) 85,439,506 (84,625,370) 814,038
Balance (in Shares) at Mar. 31, 2026 3,045 741,578        
Balance (in Shares) at Mar. 31, 2026     39      
Balance at Dec. 31, 2025 $ 1 $ 21 $ (172) 85,438,530 (82,350,149) $ 3,088,231
Balance (in Shares) at Dec. 31, 2025 6,875 211,976       211,976
Balance (in Shares) at Dec. 31, 2025     39     39
Net loss           $ (3,638,032)
Balance at Jun. 30, 2026 $ 152 $ (172) 87,724,581 (85,988,181) $ 1,736,380
Balance (in Shares) at Jun. 30, 2026 1,522,359       1,522,359
Balance (in Shares) at Jun. 30, 2026     39     39
Balance at Mar. 31, 2026 $ 74 $ (172) 85,439,506 (84,625,370) $ 814,038
Balance (in Shares) at Mar. 31, 2026 3,045 741,578        
Balance (in Shares) at Mar. 31, 2026     39      
Stock-based compensation expense 153 153
Issuance of common stock in connection with PIPE financing $ 8 2,499,992 2,500,000
Issuance of common stock in connection with PIPE financing (in Shares)   85,202        
Reversal of issued common stock through conversion of Series C convertible preferred stock due to error on issuance $ (3)   3
Reversal of issued common stock through conversion of Series C convertible preferred stock due to error on issuance (in Shares) 116 (30,517)        
Effect of reverse split stock on outstanding common stock
Effect of reverse split stock on outstanding common stock (in Shares)   47        
Offering costs in connection with PIPE financing (215,000) (215,000)
Issuance of common stock through conversion of Series C convertible preferred stock $ 73 (73)
Issuance of common stock through conversion of Series C convertible preferred stock (in Shares) (3,161) 726,049        
Net loss (1,362,811) (1,362,811)
Balance at Jun. 30, 2026 $ 152 $ (172) $ 87,724,581 $ (85,988,181) $ 1,736,380
Balance (in Shares) at Jun. 30, 2026 1,522,359       1,522,359
Balance (in Shares) at Jun. 30, 2026     39     39